BioNTech SE - ADR

NASDAQ:BNTX  
109.93
+4.97 (+4.74%)
Products

Pfizer And Biontech To Submit Emergency Use Authorization Request Today To U.S. FDA For COVID-19 Vaccine

Published: 11/20/2020 12:42 GMT
BioNTech SE (BNTX) - Pfizer and Biontech to Submit Emergency Use Authorization Request Today to the U.S. FDA for Covid-19 Vaccine.
Biontech Se - Companies Will Be Ready to Distribute Vaccine Within Hours After Authorization.
Biontech Se - Intend to Submit Applications to Other Regulatory Agencies Worldwide in Coming Days for Covid-19 Vaccine.
Biontech Se - Pfizer and Co Plan to Submit Efficacy & Safety Data From Study for Peer-review in Scientific Journal Once Analysis of Data is Completed.